Hyperactivity

...ba href=/hyperactivity/a/b disorder (ADHD) in children and teenagers, U.S.

health experts unanimously said on Thursday.

The Food and Drug Administration panel of outside advisers said company data on the stimulant drug, currently approved for sleep disorders, showed it worked for ADHD.

The FDA will make the final decision but usually follows the advice of its advisers.

© Reuters 2006.

All Rights Reserved.

More Health Medical safety net shrinks with less charity care Delayed-release Ritalin has less potential for abuse Foundation opens TB vaccine plant, no product yet Younger breast cancer patients more at risk: study Kids with HIV often have behavioral problems MORE Reuters.co.uk Help & Info Careers ...

...ba href=/hyperactivity/a/b disorder (ADHD) in children and teenagers, U.S.

health experts unanimously said on Thursday.

The Food and Drug Administration panel of outside advisers said company data on the stimulant drug, currently approved for sleep disorders, showed it worked for ADHD.

The FDA will make the final decision but usually follows the advice of its advisers.

Copyright 2006 Reuters News Service.

All rights reserved.

This material may not be published, broadcast, rewritten, or redistributed.

Print This StoryPrint This Story E-mail This ArticleEmail This Article RSS Headlines Newsletters Cigarette Suspected in Cruise Ship Fire U.S., British Troops Rescue Iraq Hostages At Least 56 Dead in Latest Iraq Violence Most Sent Headlines Iraq Archive Document Describes Bin Laden MeetingSexless and ProudLos Angeles Man Retires at 100 ABC News Home Contact ABC News .

ABC.com .

Help & Info .

Advertising Info .

Terms of Use .

Privacy Policy/Your California Privacy Rights Copyright © 2006 ABC News Internet Ventures ...

...ba href=/hyperactivity/a/b disorder in children and teens.

March 23, 2006: 2:52 PM EST GAITHERSBURG, Md.

(Reuters) - Cephalon Inc.'s Sparlon drug effectively treats attention deficit ba href=/hyperactivity/a/b disorder (ADHD) in children and teenagers, health experts unanimously said Thursday.

The Food and Drug Administration panel of outside advisers said company data on the stimulant drug, currently approved for sleep disorders under the name of Provigil, showed it worked for ADHD.

The FDA will make the final call on the drug, but it usually follows the advice of its advisers.

Shares of Cephalon (Research) were halted on the Nasdaq.

-- Big Pharma thinks small.

Click here.

SAVE What is this?

Special Offer: Confere...